Type-1 diabetes patients can one day avoid taking insulin injections if the bio-artificial pancreas, developed by Israel’s Beta-O2 passes its human trials in Sweden. The BAir delivers oxygen to replacements for the faulty islet cells that are essential for producing insulin in the patient’s body.
http://www.israel21c.org/headlines/beta-o2-testing-cure-for-type-1-diabetes/